Back

Benefits of patient-managed ECGs to verify the time of recurrent atrial fibrillation after electrical cardioversion in the PRE-ELECTRIC study

13 April 2023 (11:45 - 12:45)
Organised by:
Congress Presentation Part of: Moderated ePoster 1 Epidemiology, Prognosis, Outcome EAPC Premium Access ESC Preventive Cardiology 2023

About the speaker

Photo
Doctor Elizabeth Lyster Andersen

Baerum Hospital Vestre Viken Trust, Gjettum (Norway)

7 More presentations in this session

Presentation thumbnail
Prognosis of various atrial fibrillation patterns in the general population
Mr M. Tilly (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Proteomics and recurrence of atrial fibrillation: a pilot study nested in the PREDIMAR trial
Doctor C. Razquin (Pamplona, ES)
Abstract Slides
Presentation thumbnail
Follow-up results of a cohort of patients undergoing electrical cardioversion. Recurrence and associated factors in the medium to long term
Mr D. Aguila Gordo (Ciudad Real, ES)
Abstract Slides
Presentation thumbnail
Predictors of success of elective electrical cardioversion in patients with atrial fibrillation and atrial flutter
Mr D. Aguila Gordo (Ciudad Real, ES)
Abstract Slides
Presentation thumbnail
Prevalence of left atrial thrombus in anticoagulated patients undergoing elective electrical cardioversion.
Mr D. Aguila Gordo (Ciudad Real, ES)
Abstract Slides

Access the full session

Session thumbnail
Moderated ePoster 1

The Event

Event poster

ESC Preventive Cardiology 2023

13 April 2023 11:45 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources